Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06896617

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET): a Prospective Randomized Controlled Study

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
334 (estimated)
Sponsor
Fundacion Clinic per a la Recerca Biomédica · Academic / Other
Sex
Female
Age
18 Years – 41 Years
Healthy volunteers
Accepted

Summary

In pregnancies achieved through programmed frozen embryo transfer cycle (PC-FET) and modified natural frozen embryo transfer (mNC-FET), to determine whether there are differences in endothelial and placental function, maternal cardiovascular function, fetal growth and fetal cardiovascular and cerebral programming and to assess whether there is an association between these differences and the plasma concentrations of the main secretion products of the Corpus Luteum (CL) with vasoactive and angiogenic action.

Conditions

Interventions

TypeNameDescription
DRUGEstradiol + ProgesteronePregnancies with absence of corpus luteum(PC-FET)
DRUGOvitrelle ( Hcg 250 mcg)NC-FET(natural cycle FET, endometrial preparation with presence of CL)

Timeline

Start date
2025-02-01
Primary completion
2026-11-20
Completion
2026-12-20
First posted
2025-03-26
Last updated
2025-04-02

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06896617. Inclusion in this directory is not an endorsement.